BioDelivery, a research company, has developed a treatment for chronic pain that involves a thin film strip being applied to the inside of the cheek, where it will dissolve in less than thirty minutes. The company has stated that this type of treatment is most relevant for pain patients that need rapid delivery, cannot take oral doses, or have problems with injections and intravenous lines. Endo Pharma agreed to pay up to $180 million for the licensing rights to develop and sell the drug, which is in the late stages of research.
http://www.cbsnews.com/8301-505245_162-57353646/endo-pharma-signs-licensing-deal-with-biodelivery/